Use of Atalante in paraplegic and paraparetic patients
In this clinical use case, you will find a compilation of data on the use of Atalante in paraplegic or paraparetic patients and the benefits that have been concluded.
Clinical studies sponsored by Wandercraft have provided an indication for the following impairments: complete motor paraplegia, incomplete motor paraplegia, hemiplegia secondary to stroke or any other cause of acquired brain injury.
You will read in this case study
> Chronology of the studies
> Studies summaries
> Clinical use data
> Clinical cases
Rebecca SAUVAGNAC
Physiatrist and clinical director at Wandercraft
"Gait training exoskeletons, such as Atalante X, are innovative tools in the management of people with walking impairment. They maximize rehabilitation training; in the hope of improving recovery after a neurological lesion; and in preventing the appearance of complications secondary to prolonged immobilization. Clinical studies comparing Atalante to conventional rehabilitation are undergoing to prove the potential clinical benefits.
In the long term and taking into consideration the current progress in terms of the management of Neurological lesions, particularly with the appearance of new treatments that give hope of repairing or supplementing the nervous system, exoskeletons have their place in maintaining the body in a state of general good health for people in wheelchairs."